Filing Flows › Axogen (AXGN) › Q2 2026 › vs Q2 2025
Axogen (AXGN) Q2 2026 vs Q2 2025 (year over year)
Axogen's revenue rose $13.1M (+23%) from $56.7M in Q2 2025 to $69.7M in Q2 2026.
Axogen, Q2 2026: revenue $69.7M (+23% year over year), operating margin -3.1%, net loss $1.5M, operating cash flow $7.2M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 9.1% | 12.4% | -3.3 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $69.7M | $56.7M | $13.1M | +23% |
| Other income, net | $640K | −$1.1M | $1.7M | — |
| Net loss | $1.5M | −$579K | $2.1M | — |
| Costs & expenses | $71.9M | $56.7M | $15.2M | +27% |
| Operating costs | $71.9M | $55.0M | $16.9M | +31% |
| Cost of revenue | $19.1M | $14.6M | $4.4M | +30% |
| Research & development | $8.6M | $6.9M | $1.7M | +25% |
| Sales & marketing | $30.8M | $23.8M | $7.0M | +30% |
| General & admin | $13.4M | $9.7M | $3.7M | +38% |
| Operating cash sources | $10.5M | $6.9M | $3.6M | +52% |
| Depreciation & amortization | $1.7M | $1.7M | −$5K | -0.3% |
| Share-based compensation | $8.8M | $5.2M | $3.6M | +70% |
| Net loss absorbed | $1.5M | −$579K | $2.1M | — |
| Working capital & other | $1.7M | −$260K | $2.0M | — |
| Operating cash flow | $7.2M | $7.7M | −$509K | -7% |
| Free cash flow (OCF − capex) | $6.3M | $7.0M | −$680K | -10% |
| Capital expenditures | $893K | $722K | $171K | +24% |
Questions
How much did Axogen's revenue grow year over year in Q2 2026?
Axogen's revenue rose $13.1M (+23%) from $56.7M in Q2 2025 to $69.7M in Q2 2026.